Literature DB >> 2563734

Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.

A C Faria1, J D Veldhuis, M O Thorner, M L Vance.   

Abstract

The half-life (t1/2) of disappearance of endogenous GH from serum was studied using physiological effectors to stimulate and then suppress GH release. GH secretion was stimulated by a single iv injection of GHRH, followed 45 min later by an iv bolus dose and then a 2.5-h infusion of somatostatin (SRIH) to suppress further release. The in vivo t1/2 of GH in seven men was calculated from serum GH concentrations measured at frequent intervals after beginning the SRIH infusion. The mean t1/2 of endogenous GH was 18.9 +/- 0.8 (+/- SE) min by monoexponential analysis and 3.5 +/- 0.7 and 20.7 +/- 0.7 min by biexponential fitting. In these normal men, the decline in GH concentrations after GHRH and SRIH administration was similar to that after the administration of GHRH alone, which yielded a t1/2 of 20.3 +/- 1.9 min. We conclude that the physiological kinetics of endogenous GH removal/disappearance can be estimated in vivo in man using GHRH with or without SRIH infusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563734     DOI: 10.1210/jcem-68-3-535

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Daniel M Keenan; Steven Pincus
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

2.  Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women.

Authors:  Johannes D Veldhuis; Susan A Hudson; Joy N Bailey; Dana Erickson
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

3.  Thioamide Substitution Selectively Modulates Proteolysis and Receptor Activity of Therapeutic Peptide Hormones.

Authors:  Xing Chen; Elizabeth G Mietlicki-Baase; Taylor M Barrett; Lauren E McGrath; Kieran Koch-Laskowski; John J Ferrie; Matthew R Hayes; E James Petersson
Journal:  J Am Chem Soc       Date:  2017-11-13       Impact factor: 15.419

4.  Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults.

Authors:  Johannes D Veldhuis; Leon Farhy; Arthur L Weltman; Jonathan Kuipers; Judith Weltman; Laurie Wideman
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

5.  Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men.

Authors:  Ali Iranmanesh; Donna Lawson; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2012-04-03       Impact factor: 5.958

6.  Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.

Authors:  Catalina Norman; Nanette L Rollene; Dana Erickson; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Eur J Endocrinol       Date:  2013-11-29       Impact factor: 6.664

7.  Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adenborduin Adeniji; John M Miles; Remberto Paulo; Mihaela Cosma; Cacia Soares-Welch
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

8.  Differential pulsatile secretagogue control of GH secretion in healthy men.

Authors:  Catalina Norman; John Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-13       Impact factor: 3.619

9.  Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.

Authors:  Arthur Weltman; Judy Y Weltman; Dee Dee Watson Winfield; Kirsten Frick; James Patrie; Petra Kok; Daniel M Keenan; Glenn A Gaesser; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

10.  Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adebordurin M Adeniji; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.